Aeras announced that Lota S. Zoth, CPA was appointed Chair of its Board of Directors, noting that Ms. Zoth “assumes leadership of Aeras during its 10th year, at a time when the organization is focused on diversifying and advancing a pipeline of next-generation vaccine candidates.” Ms. Zoth joined the board in 2011 and is a strategic finance and operations executive who served as Senior Vice President and Chief Financial Officer of MedImmune, Inc., now part of AstraZeneca. She replaces R. Gordon Douglas, Jr., outgoing Chair of the Board and Emeritus Professor of Medicine at Weill Cornell Medical College. Dr. Douglas served as Board Chair for the past 12 years and “guided the organization through its growth from a small nonprofit research group to an international nonprofit biotech with offices in South Africa and China; six TB vaccine candidates in its clinical portfolio; and global partnerships in Africa, Asia, Australia, Europe, and North America.”
November 21, 2013, ROCKVILLE, MD – http://www.aeras.org/pressreleases/aeras-announces-new-board-leadership#.UpEwd-Ky-F8